Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel

Vaccine

Volumn 32, Issue 33, 2014, Pages 4198-4205

  Yamin, Dan ^a   Balicer, Ran D ^b   Galvani, Alison P ^a  

^a YALE UNIVERSITY   (United States)

^b CLALIT HEALTH SERVICES   (Israel)

Author keywords

Cost effectiveness; Influenza and pneumonia; Influenza vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; ISRAEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTPATIENT CARE; PNEUMONIA; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; ISRAEL; MIDDLE AGED; PNEUMONIA; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; RISK FACTORS; VACCINATION; YOUNG ADULT;

EID: 84903442525     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.015     Document Type: Article

References (41)

1. Rudan I., Boschi-Pinto C., Biloglav Z., Mulholland K., Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008, 86:408-416.
2. Shrestha S., Foxman B., Weinberger D.M., Steiner C., Viboud C., Rohani P. Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med 2013, 5:191ra84.
3. Grohskopf L., Shay D.K., Shimabukuro T., Sokolow L., Keitel W., Bresee J.S., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-United States, 2013-2014 2013.
4. Nichol K.L., NJ D., Nelson D.B., Mullooly J.P., Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007, 357:1373-2138.
5. Stephenson I., Hayden F., Osterhaus A., Howard W., Pervikov Y., Palkonyay L., et al. Report of the fourth meeting on "Influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009. Vaccine 2010, 28:3875-3882.
6. Balicer R.D., Huerta M., Davidovitch N., Grotto I. Cost-benefit of stockpiling drugs for influenza pandemic. Emerg Infect Dis 2005, 11:1280-1282.
7. Prevention and control of influenza in Israel. Isr Minist Heal 2012, http://www.health.gov.il/Subjects/vaccines/Pages/Winter_flu.aspx.
8. Flory J.H., Joffe M., Fishman N.O., Edelstein P.H., Metlay J.P. Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiol Infect 2009, 137:717-726.
9. Fonseca W., Kirkwood B.R., Victora C.G., Fuchs S.R., Flores J.A., Misago C. Risk factors for childhood pneumonia among the urban poor in Fortaleza, Brazil: a case-control study. Bull World Health Organ 1996, 74:199-208.
10. Metlay J.P., Fine M.J. Testing strategies in the initial management of patients with pneumonia, community-acquired. Ann Intern Med 2003, 138:109-119.
11. Bang A.T., Bang R.A., Tale O., Sontakke P., Solanki J., Wargantiwar R., et al. Reduction in pneumonia mortality and total childhood mortality by means of community-based intervention trial in Gadchiroli, India. Lancet 1990, 336:201-206.
12. Rothberg M.B., Haessler S., Brown R. Complications of viral influenza. Am J Med 2008, 258-264.
13. Weinberger D., Harboe Z., Viboud C., Krause T., Miller M.K.M., Mølbak K., et al. Serotype-Specific Effect of Influenza on Adult Invasive Pneumococcal Pneumonia. J Infect Dis 2013, 208:1274-1280.
14. The Israeli Bereau of Statistics-population in Israel. Isr Bereau Stat 2012, 1.
15. Surveillance of influenza like illness in Israel. Isr Cent Dis Control Prev 2014, http://www.old.health.gov.il/pages/default.asp?pageid=5312&parentid=507&catid=78&maincat=25.
16. Huss A., Scott P., Stuck A.E., Trotter C., Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009, 180:48-58.
17. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008, 372:398-405.
18. Ferdinands J.M., Gargiullo P., Haber M., Moore M., Belongia E.A., Shay D.K. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies. Epidemiology 2013, 24:530-537.
19. Molinari N.-A.M., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
20. Ryan J., Zoellner Y., Gradl B., Palache B., Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006, 24:6812-6822.
21. Ministry of Health price lists. Isr Minist Heal 2014, http://www.health.gov.il/subjects/finance/taarifon/pages/pricelist.aspx.
22. CDC - VFC current vaccine price list - vaccines for children program. US Centers Dis Control Prev 2014, http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html.
23. Fiore A.E., Uyeki T.M., Broder K., Finelli G.L., Singleton J., Iskander J.K., et al. Prevention and control of influenza with vaccines 2010.
24. Briss P.A., Rodewald L.E., Hinman A.R., Shefer A.M., Strikas R.A., Bernier R.R., et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med 2000, 18:97-140.
25. Yamin D., Gavious A., Solnik E., Davidovitch N., Balicer R.D., Galvani A.P., et al. Innovative influenza Vaccination Policy: Targeting Last Season's Patients. PLoS Comput Biol 2014, 10. e1003643.
26. Siddiqui M.R., Edmunds W.J. Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic. Emerg Infect Dis 2008, 14:267-274.
27. Edejer T., Baltussen R., Adam T., Hutubessy R., Acharya A., Evens D., et al. WHO guide to cost-effectiveness analysis 2002.
28. Baguelin M., Jit M., Miller E., Edmunds W.J. Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine 2012, 30:3459-3462.
29. Ament A., Baltussen R., Duru G., Rigaud-Bully C., de Graeve D., Ortqvist A., et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin Infect Dis 2000, 31:444-450.
30. Rozenbaum M.H., van Hoek A.J., Fleming D., Trotter C.L., Miller E., Edmunds W.J. Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ 2012, 345:e6879.
31. Baguelin M., Van Hoek A.J., Jit M., Flasche S., White P.J., Edmunds W.J. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine 2010, 28:2370-2384.
32. Prosser L.A., Bridges C.B., Uyeki T.M., Hinrichsen V.L., Meltzer M.I., Molinari N.-A.M., et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis 2006, 12:1548-1558.
33. Hunink M., Paul G., Joanna S., Jane W., Joseph P., Arthur E., et al. Decision making inhealth and medicine 2001, Cambridge University Press, Cambridge, UK.
34. WHO International Classification of Diseases (ICD) 2014, World Heal Organ, Cambridge, UK.
35. Mclntosh K. community acquired pneumonia in children. N Engl J Med 2002, 346.
36. Brewer N.T., Chapman G.B., Gibbons F.X., Gerrard M., McCaul K.D., Weinstein N.D. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol 2007, 26:136-145.
37. 2013 recommendations of health basket. Isr Minist Heal 2013, http://www.health.gov.il/Services/Committee/vsal/HSB2013/DocLib/Sal-2013_25122012.pdf.
38. Chodick G., Waisbourd-Zinman O., Shalev V., Kokia E., Rabinovich M., Ashkenazi S. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel. Eur J Public Health 2009, 19:254-259.
39. Ginsberg G.M., Fisher M., Ben-Shahar I., Bornstein J. Cost-utility analysis of vaccination against HPV in Israel. Vaccine 2007, 25:6677-6691.
40. Council reccomendations on seasonal influenza vaccination. Off J Eur Union 2009, 348:71-72.
41. Health at a glance 2011: OECD indicators 2011, OECD Publishing.